Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SPRY | ELVN | AVDL | ||
| Company | Ars Pharmaceuticals Inc | Enliven Therapeutics Inc | Avadel Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 11.18 | 22.51 | 9.99 | ||
| High | 11.56 | 22.99 | 10.53 | ||
| Low | 10.83 | 21.83 | 9.98 | ||
| Last | 11.18 | 22.47 | 10.31 | ||
| Change | -0.14 | -0.40 | +0.20 | ||
| % Change | -1.24% | -1.75% | +1.98% | ||
| Volume | 2,578,100 | 395,200 | 1,168,900 | ||
| 20-Day Average Volume | 1,121,855 | 204,655 | 1,252,210 | ||
| Previous Close | 11.32 | 22.87 | 10.11 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 13.03 | 23.91 | 10.58 | ||
| 20-Day Raw Stochastic | 12.88% | 17.73% | 32.03% | ||
| 20-Day Relative Strength | 36.51% | 40.93% | 41.10% | ||
| Weighted Alpha | +63.40 | -0.41 | -21.93 | ||
| Today's Opinion | 24% Sell | 24% Sell | 100% Sell | ||
| Previous Opinion | 24% Sell | 8% Sell | 100% Sell | ||
| Last Month's Opinion | 56% Buy | 56% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.05% since 12/13/24 | -2.94% since 12/13/24 | -0.77% since 12/13/24 | ||
| Low | 10.63 on 12/18/24 | 21.83 on 12/20/24 | 9.98 on 12/20/24 | ||
| High | 12.39 on 12/16/24 | 24.42 on 12/17/24 | 11.15 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | -17.49% since 11/20/24 | -11.64% since 11/20/24 | -4.09% since 11/20/24 | ||
| Low | 10.63 on 12/18/24 | 21.69 on 12/12/24 | 9.41 on 12/03/24 | ||
| High | 14.90 on 11/29/24 | 26.09 on 11/22/24 | 12.22 on 11/22/24 | ||
| 3-Month | |||||
| %Chg | -24.31% since 09/20/24 | -3.10% since 09/20/24 | -23.06% since 09/20/24 | ||
| Low | 10.63 on 12/18/24 | 21.69 on 12/12/24 | 9.41 on 12/03/24 | ||
| High | 18.51 on 11/11/24 | 30.03 on 10/18/24 | 16.66 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +44.63% since 06/20/24 | +6.80% since 06/20/24 | -31.17% since 06/20/24 | ||
| Low | 7.55 on 06/25/24 | 19.88 on 06/26/24 | 9.41 on 12/03/24 | ||
| High | 18.51 on 11/11/24 | 30.03 on 10/18/24 | 17.30 on 08/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,086,528 | 1,097,862 | 993,492 | ||
| Shares Outstanding, K | 97,185 | 48,859 | 96,362 | ||
| Annual Sales | 30,000 | 0 | 27,960,000 | ||
| Annual Net Income | -54,370,000 | -71,580,000 | -160,280,000 | ||
| Last Quarter Sales | 2,070,000 | 0 | 50,030,000 | ||
| Last Quarter Net Income | -19,130,000 | -23,160,000 | -2,630,000 | ||
| 60-Month Beta | 0.88 | 1.02 | 1.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.20 on 11/13/24 | -0.48 on 11/13/24 | -0.03 on 11/12/24 | ||
| Latest Earnings Date | 11/13/24 | 11/14/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||